Although one might have expected higher BAFF levels to be associated with an increased risk of CLL because BAFF promotes the survival of CLL clones through the canonical NF-κB pathway, this pathway is not used in normal B-cells [17]. This evidence concerns the gene NFKB1 and B-cell chronic lymphocytic leukemia.